Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Navigating the Medical Device Consulting Landscape: Key Considerations

Jul 01, 2026By Sreejith Kanhirangadan

SK

Understanding the Role of Medical Device Consultants

In the ever-evolving field of medical devices, consultants play a crucial role in guiding companies through complex regulatory landscapes, helping them bring innovative products to market. These experts provide a wealth of knowledge in areas such as compliance, quality assurance, and market strategy, making them invaluable assets to both startups and established firms.

Consultants often come equipped with extensive experience in the medical device industry, allowing them to offer insights that can streamline product development processes. By understanding the specific needs and challenges of each client, they help tailor strategies that align with business goals and regulatory requirements.

medical device consultant

Choosing the Right Consultant

When selecting a medical device consultant, it's essential to consider their expertise and track record. Look for professionals with a proven history of successfully navigating regulatory pathways and bringing products to market. Experience in your specific product category can also be a significant advantage.

Another key consideration is the consultant's network. A well-connected consultant can facilitate introductions to key players in the industry, including regulatory bodies, potential partners, and investors. This network can be instrumental in overcoming hurdles and accelerating the approval process.

Regulatory Compliance and Strategy

One of the primary reasons companies engage medical device consultants is to ensure compliance with stringent regulations. These professionals are well-versed in FDA, CE, and other international standards, helping companies avoid common pitfalls that can delay product launches.

regulatory compliance

Consultants also assist in developing regulatory strategies that align with business objectives. They help determine the most efficient pathways to market, whether through traditional approvals or newer, expedited processes. Their expertise can lead to significant time and cost savings.

Quality Assurance and Risk Management

Quality assurance is a critical component of medical device development. Consultants help establish robust quality management systems that comply with international standards, ensuring that products are safe and effective for end-users.

Risk management is another area where consultants add value. They conduct thorough risk assessments, identifying potential issues early in the development process. By implementing effective risk mitigation strategies, they help protect companies from costly recalls or legal challenges.

quality assurance

Market Strategy and Commercialization

Beyond regulatory compliance, medical device consultants provide strategic insights into market entry and commercialization. They help identify target markets, assess competitive landscapes, and develop marketing strategies that resonate with key stakeholders.

Consultants also play a role in pricing strategy and distribution channel selection, ensuring that products reach their intended audience efficiently and effectively. Their market knowledge can be instrumental in achieving commercial success.

Conclusion

Navigating the medical device consulting landscape requires careful consideration of various factors, from regulatory expertise to market strategy. By selecting the right consultant, companies can enhance their development processes, achieve regulatory compliance, and successfully bring their products to market. Ultimately, the right consultant can be a pivotal partner in driving innovation and growth in the medical device industry.